chrisvoncsefalvay/vaers-outcomes huggingface dataset:
pt stated that instantaneously after getting the covid vax she got a metal taste in side of her mouth and her tongue felt funny.  She had a tingling inside her mouth behind her teeth.  She was administered Benadryl.  She then got a tingling inside of the throat that moved down into her chest.  First Response team  was called.  She was having SOB.  She was moved to the ER where she was given more Benadryl and prednisone.  After that she had tingling in her lips as they were warm and puffy.  She was released around noon.  About 1:00 PM the same day pt started having SOB and the same bad taste in her mouth along with all of the other symptoms.  She took another Benadryl at 1:54 PM.   At 3PM she was sleeping and woke with tingling and hotness in her lips.  She started coughing and having trouble catching her breath.  This symptoms went away and came back at 3:46 pm.  She then again developed the same symptoms all over again but this also included swelling in the back of the tongue.   She took another Benadryl at 6:28 PM and then again at 10:28. About 11PM she got these mouth symptoms again along w/ really itchy feet and back.  She woke up at 5:50 AM she felt fine. At 8:00 AM she woke up and had the strange metal taste in her mouth along with a strange feeling in it.   At 11AM she had mild episode of the SOB and coughing.  At 3:15 she still has this taste in her mouth along with the strange feeling.  Pt is waiting on a CB from her PCP.
Passed out cold around 8 a.m. when heading to bathroom. He doesn't remember anything; woke up at some point  half in and half out of his closet; injured elbow. Other symptoms beginning during the night were dizziness, weakness, headache, nausea, fever of 101, chills, extreme fatigue.
Client completed 15 minutes in the observation area and walked to the EMT station. EMt asked the client if she was feeling good. The client reported that she feels, " a little bit dizzy." RN Withers recommended the client stay in observation due to the dizziness. The client stated she wanted to go sit back in her seat. RN and EMT responded to the client at 1:49PM. The client said she felt, "A little bit lightheaded when I stood up." The client reported a history of low blood pressure. The client has a history of anaphylaxis related to anesthesia. The client reported a history of anxiety. Vitals obtained by EMT at 1:51PM were as follows: automatic BP 114/86, O2 99%, HR 74. The client denied any persistent symptoms. The client stated she has only consumed coffee and a cookie today. The client requested to leave the vaccination site against medical advice. RN provided education regarding s/s of anaphylaxis and when to seek EMS. The client voiced understanding of this education.
Received my first dose of COVID-19 vaccine on 12/27/2020. Had some muscular pain in injection arm (left) for 48 hrs. But, one week later had redness in the left upper arm and muscular pain with certain movements. I still have some mild pain with certain movements of that arm, nothing that limits my activities.
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 65-year-old female patient (not pregnant) received bnt162b2, bnt162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 06Nov2022 as dose 3 (booster), single (Batch/Lot number: unknown) at the age of 64 years for covid-19 immunisation; covid-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown) and as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient had no relevant medical history. The patient's concomitant medications were not reported. The patient had no known allergy.  The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "Treatment of COVID-19". Therapeutic measures were taken as a result of drug ineffective, covid-19 including Paxlovid from 02Sep2023 to 06Sep2023.  The information on the batch/lot number for bnt162b2, bnt162b2 omi ba.4-5 has been requested and will be submitted if and when received.
Per Dr "Pain in area of injection with limited motion and painful motion." Per Dr, developed hematoma within minutes of administration and pain and decreased mobility continue, particularly unable to raise arm above shoulder level.
CHILLS  ,FEVER, TIRED AND RIGH NOW TODAY 22APRIL VEIN VERY INFLAMED LIKE A CORD AND IT HURTS A LOT OF TO RAISE AND LOWER MY ARM LEFT  I AM VERY AFRAID THAT IT IS A THROMBUS.
Patient was mistakenly given influenza shot instead of the Bivalent COVID-19 shot. No symptoms at this time.
difficulty thinking; brain fog; Injection site pain and swelling; Injection site pain and swelling; axillary lymph node swelling; wrist pain and swelling/joint pain; wrist pain and swelling; muscle and joint pain; skin pain; kidney and liver pain; kidney and liver pain; dizziness; nausea; weakness; fatigue; chilling; This is a spontaneous report from a contactable nurse (patient). A 49-year-old female patient (not pregnant) received first dose bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot/batch number and expiry date were not provided), intramuscular in right arm on 22Dec2020 14:30 at single dose for COVID-19 immunisation.  Facility where the most recent COVID-19 vaccine was administered was hospital. Medical history included asthma.  Prior to vaccination, the patient was not diagnosed with COVID-19. No allergies to medications, food, or other products. Concomitant medication included fluticasone propionate, salmeterol xinafoate (ADVAIR).  The patient experienced Injection site pain and swelling, axillary lymph node swelling, wrist pain and swelling, muscle and joint pain, skin pain, kidney and liver pain, dizziness, nausea, weakness, fatigue, chilling, difficulty thinking, brain fog on 23Dec2020 01:15. Symptoms lasting x 6 days. The patient not received any other vaccines within 4 weeks prior to the COVID vaccine. No treatment received for the adverse event. Since the vaccination, the patient has not been tested for COVID-19. The outcome of events was reported as recovering.  Information about lot/batch number are requested.; Sender's Comments: Based on available information, a possible contributory role of the subject product, BNT162B2 vaccine, cannot be excluded for the difficulty thinking, brain fog and other reported events due to temporal relationship.  There is limited information provided in this report.  Additional information is needed to better assess the case, including complete medical history, diagnostics including head CT/MRI and chemistry panel, counteractive treatment measures and concomitant medications. This case will be reassessed once additional information is available.  The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.
Around 10 minutes after vaccination, patient reported back spasms that radiating around to her chest.  After sitting to rest her back pain eased up but she reported to a hospital for examination.
I got both shots and a few years ago I got the shingles again/ Suspected vaccination failure; Shingles; This serious case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Co-suspect products included Herpes zoster (Shingles vaccine) for prophylaxis.   The patient's past medical history included shingles.   On an unknown date, the patient received the 2nd dose of Shingles vaccine and the 1st dose of Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine and Shingles vaccine, the patient experienced vaccination failure (Verbatim: I got both shots and a few years ago I got the shingles again/ Suspected vaccination failure) (serious criteria GSK medically significant) and shingles (Verbatim: Shingles). The outcome of the vaccination failure was unknown and the outcome of the shingles was not reported.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine and Shingles vaccine.     It was unknown if the company considered the vaccination failure and shingles to be related to Shingles vaccine and Shingles vaccine.   Additional Information: GSK Receipt Date: 20-JUN-2023 This case was reported by a patient via interactive digital media. The patient reported that he or she had shingles and then received two doses of Shingles vaccine and few years ago again experienced shingles. This case was considered as suspected vaccination failure as details regarding time to onset for shingles and laboratory confirmation regarding shingles were unknown at the time of reporting. Follow-up would not possible as no contact details were available.
pt recv vax 27JUL95 & 11JUN97 pt presented to MD office w/chickenpox;
Sore muscle pain feels like a Charlie horse; Sharp stabbing pain near the top of my arm; Sharp stabbing pain near the top of my arm that radiated down towards my chest; This is a spontaneous report from a contactable consumer or other non-health care professional (Patient). A 53-year-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot number and expiration was not reported), second dose via an unspecified route of administration, administered in arm left on 25Apr2021 13:00 (at the age of 53 years) as single for covid-19 immunization. Medical history included Past Multiple back surgeries, neck surgeries from an unknown date and unknown if ongoing. There were no concomitant medications. Patient had no reported allergies. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Patient was not diagnosed with COVID-19, prior vaccination and since the vaccination. Historical vaccine included bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot number and expiration was not reported), first dose via an unspecified route of administration, administered in arm left on 29Mar2021 16:00 (at the age of 53 years) as single for covid-19 immunization. On 25Apr2021 16:00 the patient experienced Sharp stabbing pain near the top of my arm that radiated down towards my chest and Sore muscle pain feels like a Charlie horse all nonstop since the second vaccine. Adverse events resulted in Doctor or other healthcare professional office/clinic visit. Adverse events treatment was Medication and a follow up which is not yet scheduled. The outcome of the events was not recovered.    No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Varicella pustules on face, back and groin. Low grade fever. Tx with Valtrex per ER.
Dose received: 3; Fever; Nausea; This is a spontaneous report from a non-contactable reporter (other healthcare professional).  A 24-year-old female patient (unknown if pregnant) received bnt162b2 (BNT162B2), administration date 12Jan2022 (Lot number: FD7218) at the age of 24 years as dose 3 (booster), single for COVID-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (DOSE 1; MANUFACTURER UNKNOWN; Lot number: unknown; Route of administration: unspecified), for COVID-19 immunisation and Covid-19 vaccine (DOSE 2; MANUFACTURER UNKNOWN; Lot number: unknown; Route of administration: unspecified), for COVID-19 immunisation. The following information was reported: IMMUNISATION (non-serious) with onset 12Jan2022, outcome "unknown", described as "Dose received: 3"; PYREXIA (non-serious) with onset an unknown date in Jan2022, outcome "unknown", described as "Fever"; NAUSEA (non-serious) with onset an unknown date in Jan2022, outcome "unknown", described as "Nausea".  No follow-up attempts are possible. No further information is expected.
pt rcvd vax; pt had allergic rxn @ inject site; was seen by MD; told needed benadryl prior to next injection; 2.5cm erythema @ inject site;
Patient received vaccination in back of store by pharmacy, waited a few minutes, then proceeded to leave with her father. Upon getting to the front of the store patient got lightheaded and fainted - her dad caught her and lowered her to the ground. Patient regained consciousness as store staff called 911. Dad and staff helped patient to sit up in a wheelchair and she got lightheaded again but did not lose consciousness. Ambulance arrived and took patient to the hospital for evaluation.
102.6 fever, muscle aches all over, extreme fatigue, eye soreness (couldn't stand any light, even through my eyelids) just barely starting to feel halfway okay a day later
On 8/15/99, the pt experienced a very faint morbilliform rash that began on her arms and upper neck. The rash was not pruritic initially but the next day did become pruritic, however, the pt did note that she had been out in the sun that day. Additionally, it was noted that the pt had just finished a course of Sulfatrim for a UTI. On 8/27/99, the rash had spread to the pt's face, arm, feet, and neck and was pruritic. The physician dx the condition as an allergic reaction and stated the rash is not varicella like, however, not sure which agent caused it. The pt was treated with Atarax. On 8/31/99, the pt recovered. No further information is available.
Patient received Pfizer COVID vaccine on 2/26/21 and 3/19/21 in another state. On 10/22/21, patient tested positive for COVID at outside facility. On 10/28/21, patient admitted to our facility for acute hypoxic respiratory failure secondary to COVID-19 pneumonia and possible concomitant superimposed bacterial pneumonia. As of today (11/1/21), patient is still admitted in our med/surg unit.
resident c/o headache and nausea before lunch. slept rest of the day. appetite poor. t97.5
Covid vaccine administered at 9:15AM. Patient began having bilateral arm rash and nausea at 9:36 AM (After 15 Min. observation)  Vitals : Spo2: 97%  Temp: 97.6  Pulse: 67  BP: 140/84 mmHg   Notified nurse practitioner patient was taken to room for additional 30 minute observation.  Vitals After 30 Minute: BP : 122/80mmHg  SpO2: 96-98 %  Symptoms were relieved and patient was sent home and advised if symptoms returned and/or worsen , she may go to nearest emergency  room. She may also contact per PCP for any concerns  and/or contact our office for further assistance.
My symptoms started about two weeks after receiving my second dose. It started off with me starting to feel really fatigue and then my asthma started to bother me at night. It seems like my asthma get worse at night. Before I decide to go to urgent care I tried taking the over the counter meds to see if that would help and my asthma only has gotten worse by then. I called the urgent care, Tuesday September  4th, 2021 to come in for a walk in. Once I arrived they checked my vitals and strep test and my blood pressure was pretty elevated. Strep came back negative. They did not give me a covid test because I had just tested negative from being tested at work. The gave me prednisone to take for 5 days. Since September 4th my symptoms are still the same really fatigue and my asthma is still flaring up. I've been in contact with my PCP. I've explained all of my symptoms to her via the online portal and I have an upcoming appointment on October 26, 2021.
Redness, swelling and itching started 2 weeks after vaccine. Still have all symptoms 24 days later
Covid Arm- itching rash started at injection site in the afternoon about 2 weeks after the injection and by evening was hot, red and approximately 2" in diameter. It spread to 4" by third day then started to dissipate.
Patient came in with what appeared to be a reaction at the injection site. Her arm had a large round raised rash. It was not directly over the injection site, it was located down her arm several inches. She said it was very painful, but did not itch.  She was going to have her doctor take a look.
Right shoulder weak, painful to move, interfering with sleep even after  2 1/2 months! Even with the help of gym trainer and owner of the gym I have been going to for 6 years.  Changing exercise program, sleep position, daily activities. Seriously affecting  daily activities.  Some clear ooze two weeks after injection. .  not painful, not pus
Dizziness, syncope. No prior meal eaten. BP 116/77; HR 64; RR 18. Water & crackers given; vital signs stable. Advised to eat lunch & hydrate. Pt stable & released from vaccination site
0855 PATIENT STATES SHE FEELS WARM ON HER LEFT ARM. PATIENT ALSO COMPLAINS THAT HER THROAT FEELS  SWOLLEN AND SHE FEELS THAT SHE HAS SOMETHING IN HER THROAT WHN SHE SWALLOWS SALIVA. NO COMPLAINTS OF PAIN   0857 BP 121/76 O2 SAT 98% PULSE 83  0915  PATIENT ADVISED OF POSSIBLE ADVERSE REACTIONS; DIFFICULTY BREATHIN G, SHORTNESS OF BREATH, SWOLLEN TONGUE OR LIPS, DIFFICULTY SWALLOWING. PATIENT ADVISED TO CALL 911 OR REPORT TO NEAREST EMERGENCY ROOM . PATIENT AWARE OF MILD SYMPTOMS OF INJECTIN: PAIN AT INJECTION SITE, BODY ACHES, HEADACHE, WARMTH AT INJECTION SITE, BODY ACHES, HEADACHE, WARMTH AT INJECTION SITE. PATIENT ADVISED TO TAKE TYLENOL OR IBUPROFEN AS NEDED FOR APIN OR FEVER. PATIENT VERBALIZED UNDERSTANDING ANS DISCHARGED ANT 0915.
Information has been received from a lawyer regarding a case in litigation concerning a female patient of unknown age. No information has been received regarding the patient's past medical history, concurrent conditions, or concomitant medication. On or about 08-MAY-2007, the patient was inoculated with ZOSTAVAX (lot number, dosage and route of administration not provided), as recommended for routine adult health maintenance for the prevention of shingles. ZOSTAVAX did not prevent shingles as intended, and the patient subsequently contracted a persistent strain of herpes zoster, also known as shingles. On or about 27-AUG-2014, the patient was treated for a blistering vesicular outbreak, which was diagnosed as severe herpes zoster, or shingles. The patient was prescribed gabapentin and acyclovir for management of her painful symptoms. As a direct and proximate result of ZOSTAVAX, and/or despite receiving ZOSTAVAX for the long-term prevention of shingles, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. The outcome of the events is unknown. Additional information has been requested.
On 5/17 I was experiencing a slight cough, runny nose, and congestion the day before my vaccine. I also started feeling some body aches. On 5/18 I took an at home Covid test which was negative and the next two days I also tested negative. On Sunday, 5/22, I tried a different brand at home Covid test and that was positive but the older brand also was coming up positive at that point. My wife and I went to the pharmacy on 5/22 for a PCR test. My positive results came back 5/23. I also tested positive on 5/22 with a rapid test at another local pharmacy. I haven't spoken with my doctor since I have only had mild symptoms. I woke up this morning on 5/25, and have lost my sense of taste and smell. I've been treating my symptoms with over the counter medication and am doing well overall.
Extremely fatigued; mucus and sinus drainage increased by 500%; electrical shock in muscles and tendons; breathing issues 02 sat is staying between 70 and 90; This is a spontaneous report from a contactable consumer (patient, self-reporting). A 55-years-old male patient received BNT162B2 (Pfizer-BioNTech COVID-19 Vaccine, Formulation: Solution for injection, Lot number: er8729 and Expiration date: unknown), via an unknown route of administration, in left arm on 22Apr2021 at 12:00 (at the age of 55-years-old) as dose number unknown, single for COVID-19 immunisation. Medical history included congestive heart failure, diabetes, bundle bunch blockage, coronary heart disease from an unknown date. The patient's concomitant medications were not reported. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient received long list of other medications within 2 weeks of vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, patient has not been tested positive for COVID-19. On 23Apr2021 at 10:00, the patient was extremely fatigued, mucus and sinus drainage increased by 500%, electrical shock in muscles and tendons, breathing issues 02 sat is staying between 70 and 90. The patient still have ongoing symptoms and issues from shot three months later. Doctor requested him not take second dose. The adverse events resulted in doctor or other healthcare professional office/clinic visit. Treatment for events included Steroids and increased treatment for congestive heart. Outcome of events reported as recovered with sequelae on an unknown date in 2021.   Follow up needed, further information has been requested.
This is a spontaneous report received from a contactable consumer or other non-HCP (the patient). A 50-year-old female patient received the 4th (booster) dose of BNT162B2 (Pfizer-BioNTech COVID-19 vaccine, batch/lot# unknown), single dose, for COVID-19 immunization. Medical history and concomitant medications not reported. Vaccination history included the 3rd (booster) dose of the COVID-19 vaccine (manufacturer unknown), the 2nd dose of the COVID-19 vaccine (manufacturer unknown), and 1st of the COVID-19 vaccine (manufacturer unknown), immunization. The patient experienced peripheral swelling, axillary pain (swelling and pain in under arm area), myalgia and arthralgia/muscle aches in shoulder and arm, with outcome of unknown. Additional information: Swelling and pain in under arm area and muscle aches in shoulder and arm after 2nd booster of Comirnaty vaccine. Symptoms only appear on side of injection. The information on the batch/lot number for BNT162B2 requested and will be submitted if/when received.